Africa Health Research Institute (AHRI)
This fully funded PhD studentship at the University College London (UCL) in partnership with the Africa Health Research Institute (AHRI) allows successful candidates to conduct research on human airway immunity against tuberculosis while residing in South Africa and the UK. The role involves utilizing advanced techniques such as single-cell RNA sequencing and systems serology to define immune landscapes and inform the design of tuberculosis vaccines. Applicants must be domiciled in South Africa and possess or be close to completing a master's degree.
Headquarters
Durban, Kwazulu-Natal, South Africa
Company Size
201-500 employees
Founded
2016
Africa Health Research Institute’s vision is optimal health and well-being of under-resourced populations.
Could symptom-free people be unknowingly passing TB to others? Major study launches in South Africa and Indonesia
Oct 23, 2025
Home-based care substantially improves blood pressure control in rural South Africa - Africa Health Research Institute
Sep 1, 2025
Africa Health Research Institute Launches in South Africa
Jul 18, 2016
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Africa Health Research Institute (AHRI).
Africa Health Research Institute (AHRI) didn’t post a salary, so this is our estimate from similar listings.
204% above the average for this role
Africa Health Research Institute secures R1.6-billion in funding to respond to urgent health challenges
Aug 29, 2023
Postdoctoral Research Associate, Adjuvant Discovery and Vaccine Development, Center for Translation Medicine
University of Montana
Senior Scientist I / II – Translational Immuno‑Oncology Research (OTR)
Novartis
Senior Scientist I / II – Translational Immuno‑Oncology Research (OTR)
Novartis
Postdoctoral Fellow
UMB AG
Postdoctoral Fellow
UMB Bank
Postdoctoral Fellow
UMB Bank